Verdiva Bio Limited, a London-based clinical-stage biopharmaceutical company, has launched with a €398.4 million ($411M USD) Series A funding round.
Copyright © 2023. Founders Today. All rights reserved
Your go-to source for the latest Startup developments.
Would you like us to send you the latest news from the startup world?